Michael Barbella, Managing Editor05.01.23
NeuroOne Medical Technologies Corporation has been awarded a U.S. patent for its proprietary electrode technology.
The patent, titled "Improved Neural Depth Probes and Related Systems and Methods," adds to NeuroOne's intellectual property portfolio, and is focused on a layered thin film neural depth electrode. The electrode could have potential applications in various procedures for both diagnostic and therapeutic use. Conditions that could potentially benefit from this technology include epilepsy, Parkinson's disease, chronic back pain due to failed back surgeries, and mood- based disorders associated with depression, severe OCD, etc.
In addition to this patent, NeuroOne's patent portfolio includes three licensed patents, eight pending U.S. applications, and several foreign applications covering various thin-film electrode technologies, including both neural and spinal cord electrodes having unique properties to optimize the functionality and minimized profile of those electrodes, enabling less invasive surgeries. More specifically, the inventions described in the patent applications include electrodes and related devices with drug delivery capabilities, spinal cord stimulation electrodes, ablation electrodes, and electrodes with temperature sensing features.
"NeuroOne is committed to protecting our electrode technology with respect to device claims and proprietary manufacturing processes," NeuroOne CEO Dave Rosa said, "With a plethora of patent applications both in the U.S. and overseas relating to procedures in epilepsy, Parkinson's disease, chronic back pain and drug/gene delivery, we believe the company is well-positioned to impact a number of key neurological conditions with patent-protected novel electrodes. We look forward to continued success with our patent applications."
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence.
The patent, titled "Improved Neural Depth Probes and Related Systems and Methods," adds to NeuroOne's intellectual property portfolio, and is focused on a layered thin film neural depth electrode. The electrode could have potential applications in various procedures for both diagnostic and therapeutic use. Conditions that could potentially benefit from this technology include epilepsy, Parkinson's disease, chronic back pain due to failed back surgeries, and mood- based disorders associated with depression, severe OCD, etc.
In addition to this patent, NeuroOne's patent portfolio includes three licensed patents, eight pending U.S. applications, and several foreign applications covering various thin-film electrode technologies, including both neural and spinal cord electrodes having unique properties to optimize the functionality and minimized profile of those electrodes, enabling less invasive surgeries. More specifically, the inventions described in the patent applications include electrodes and related devices with drug delivery capabilities, spinal cord stimulation electrodes, ablation electrodes, and electrodes with temperature sensing features.
"NeuroOne is committed to protecting our electrode technology with respect to device claims and proprietary manufacturing processes," NeuroOne CEO Dave Rosa said, "With a plethora of patent applications both in the U.S. and overseas relating to procedures in epilepsy, Parkinson's disease, chronic back pain and drug/gene delivery, we believe the company is well-positioned to impact a number of key neurological conditions with patent-protected novel electrodes. We look forward to continued success with our patent applications."
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence.